跳至主要内容
临床试验/NL-OMON42510
NL-OMON42510已完成不适用

Follow-up of intracranial aneurysms treated with the Surpass flow diverter: comparison of subtraction CTA and DSA. Part I: a prospective case cohort study - Follow-up Surpass: sCTA vs DSA. Part I.

Radboud Universitair Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • adults (age: 18 to 80) with an unruptured intracranial aneurysm treated with Surpass.

排除标准

  • subarachnoid hemorrhage, earlier coiled aneurysm, allergy (hypersensitivity to iobitridol, history of major immediate or delayed skin reaction to Iobitridol injection) or contraindication to contrast agent (manifest thyrotoxicosis, recent treatment with intravenous interleukin 2), use of nephrotoxic medicines (aminoglycosides, organoplatinum compounds, high doses of methotrexate, pentamidine, foscarnet, aciclovir, ganciclovir, valaciclovir, adefovir, cidofovir, tenofovir, vancomycin, amphotericin B, immunosuppressants such as ciclosporine or tacrolimus, ifosfamide), contraindication to CT scan, renal insufficiency, pregnancy, and age <18 years.

研究者

相似试验